3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
3
Melanoma
2
Carcinoma, Transitional Cell
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Incontinence
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Desmoid Tumors
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Cisplatin
101
Radiotherapy
53
Brachytherapy
41
Paclitaxel
37
Carboplatin
36
Surveys and Questionnaires
28
Blood Specimen Collection
20
pembrolizumab
19
Radiation
17
Magnetic Resonance Spectroscopy
17
Drug Therapy
17
Colposcopy
16
Methods
14
Bevacizumab
14
Early Intervention, Educational
12
toripalimab
11
Topotecan
11
Radiotherapy, Intensity-Modulated
11
Papanicolaou Test
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Chemoradiotherapy
11
Biopsy
11
camrelizumab
10
Mass Screening
10
Gemcitabine
10
Patient Navigation
9
Papillomavirus Vaccines
9
Nivolumab
9
Fluorodeoxyglucose F18
9
Educational Status
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Neoplasms
×
High-Intensity Focused Ultrasound Ablation
×
Clear all
NCT04116320
2025-07-14
AM-003
University of Virginia
Phase 1
Terminated
5 enrolled